Evidence map›Paper›PMID 32751340›Full record

Trial reportInternational journal of environmental research and public health2020

The Effect of Gaseous Ozone Therapy in Conjunction with Periodontal Treatment on Glycated Hemoglobin Level in Subjects with Type 2 Diabetes Mellitus: An Unmasked Randomized Controlled Trial.

Biagio Rapone, Elisabetta Ferrara, Massimo Corsalini, Ilaria Converti, Felice Roberto Grassi, Luigi Santacroce, Skender Topi, Antonio Gnoni, Salvatore Scacco, Antonio Scarano and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. The oral microbiome in autoimmune diseases: friend or foe?Journal of translational medicine · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Biagio RaponeDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0002-0062-6594
Elisabetta FerraraComplex Operative Unit of Odontostomatology, Hospital S.S. Annunziata, 66100 Chieti, Italy.ORCID 0000-0002-4831-4098
Massimo CorsaliniInterdisciplinary Department of Medicine, University of Bari, 70121 Bari, Italy.
Ilaria ConvertiDepartment of Emergency and Organ Transplantation, Division of Plastic and Reconstructive Surgery, "Aldo Moro" University of Bari, 70121 Bari, Italy.
Felice Roberto GrassiDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, "Aldo Moro" University of Bari, 70121 Bari, Italy.
Luigi SantacroceIonian Department (DJSGEM), "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0001-5671-8124
Skender TopiDepartment of Clinical Disciplines, School of Technical Medical Sciences, University A. Xhuvani, 3001 Elbasan, Albania.
Antonio GnoniDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, "Aldo Moro" University of Bari, 70121 Bari, Italy.
Salvatore ScaccoDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0003-2717-2489
Antonio ScaranoDepartment of Oral Science, Nano and Biotechnology and CeSi-Met University of Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0003-1374-6146
Maurizio DelvecchioDepartment of Metabolic and Genetic Diseases, Giovanni XXIII Children's Hospital, 70126 Bari, Italy.ORCID 0000-0002-1528-0012
University of Bari Aldo Moro · ITOspedale Pediatrico Giovanni XXIII · ITOspedale SS. Annunziata · ITUniversity of Chieti-Pescara · ITUniversity of Elbasan · AL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is established that inflammation is involved in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) by promoting insulin resistance and impaired beta cell function in the pancreas. Among the hypothesized independent risk factors implicated in the pathogenetic basis of disease, periodontal infection has been proposed to promote an amplification of the magnitude of the advanced glycation end product (AGE)-mediated upregulation of cytokine synthesis and secretion. These findings suggest an interrelationship between periodontal disease and type 2 diabetes, describing poor metabolic control in subjects with periodontitis as compared to nondiabetic subjects and more severe periodontitis in subjects with T2DM as compared to a healthy population, with a significant positive correlation between periodontal inflammatory parameters and glycated hemoglobin level. Results from clinical trials show that periodontal treatment is able to improve glycemic control in subjects with diabetes. Many therapeutic strategies have been developed to improve periodontal conditions in conjunction with conventional treatment, among which ozone (O

methodsThis study was a 12-month unmasked randomized trial and included 100 patients aged 40-74 years older, with type 2 diabetes mellitus diagnosed. All the patients received conventional periodontal treatment, or periodontal treatment in conjunction with ozone gas therapy in a randomly assigned order (1:1). The primary outcome was a clinical measure of glycated hemoglobin level at 3, 6, 9 and 12 months from randomization. Secondary outcomes were changes in periodontal inflammatory parameters.

resultsAt 12 months, the periodontal treatment in conjunction with ozone gas therapy did not show significant differences than standard therapy in decreasing glycated hemoglobin (HbA1C) level and the lack of significant differences in balance is evident.

conclusionsAlthough the change was not significant, periodontal treatment in conjunction with the gaseous ozone therapy tended to reduce the levels of glycated hemoglobin. The study shows a benefit with ozone therapy as compared to traditional periodontal treatment.

Indexed as

Diabetes Mellitus, Type 2Glycated HemoglobinOzonePeriodontal DiseasesAdultAgedBlood GlucoseHumansMiddle AgedBlood GlucoseGlycated HemoglobinOzonegaseous ozone therapyperiodontal diseaseperiodontal treatmentperiodontitistype 2 Diabetes

Identifiers

PMID32751340
PMCPMC7432743
OpenAlexW3045922753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.